- Country: Belgium
- Summary: Fourniture 'D'anastroazole, Anagrelide, Letrozole, Bevacizumab, Bortezomib Et De Fulvestrant 2023-2027
- BET Ref No: 84836987
- Deadline: 01 Aug 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 378685-2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- This bundle contract is for the supply of anastroazole, anaglelide, letrozole, bevacizumab, bortezomib and fulvestrant in different strengths and dosage forms.
Doc Title: Pharmaceutical products
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINFourniture 'D'anastroazole, Anagrelide, Letrozole, Bevacizumab, Bortezomib Et De Fulvestrant 2023-2027 - Belgium Tender
The PUBLIC HEALTH INTERMUNICIPAL AUTHORITY OF THE PAYS DE CHARLEROI SC, a Government sector organization in Belgium, has announced a new tender for Fourniture 'D'anastroazole, Anagrelide, Letrozole, Bevacizumab, Bortezomib Et De Fulvestrant 2023-2027. This tender is published on BelgiumTenders under BET Ref No: 84836987 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-08-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
